EINSTEIN PEER REVIEWER
David M. Kaufman, MD
Professor of Neurology and Psychiatry
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, New York
PHYSICIAN CONTINUING MEDICAL EDUCATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and RMEI Medical Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Albert Einstein College of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE OF CONFLICTS OF INTEREST
The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relevant relationship(s) with a pharmaceutical, product, or device company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. Albert Einstein College of Medicine, CCME staff, has no relevant conflicts of interest with commercial interests related directly or indirectly to this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
- Robert A. Hauser, MD, MBA, has affiliations with Adamas Pharmaceuticals, Biotie Therapies, Cynapsus Therapeutics, ERT, Jefferies, Lundbeck, Neuropore, Neurocrine Biosciences, Sarepta Therapeutics, Teva, US WorldMeds (Consulting Fees); University of South Florida (Salary); Acadia Pharmaceuticals, Acorda, Adagio Pharmaceuticals, AstraZeneca, Biotie Therapies, Impax Pharmaceuticals, Intec, Kyowa, Lundbeck, Michael J. Fox Foundation, Pfizer, Pharma Two B, Revance Therapeutics, Sarepta Therapeutics (Clinical Research).
- Kelly Tehan, PA-C, has no affiliations with commercial interests to disclose.
RMEI Medical Education, LLC
- Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
- Barbara Martin, MD, has no affiliations with commercial interests to disclose.
- Nora Hartley has no affiliations with commercial interests to disclose.
- Amy Reeve has no affiliations with commercial interests to disclose.
Albert Einstein College of Medicine
- David M. Kaufman, MD, has no affiliations with commercial interests to disclose.
- Victor Hatcher, PhD, Associate Dean, has no affiliations with commercial interests to disclose.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine, RMEI Medical Education, LLC, and AbbVie. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Estimated time to complete: 2.0 hours
There is no fee for this educational activity.
This activity is supported by an independent medical educational grant from AbbVie.
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 2.0 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the activity evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.